LONDON, Sept. 28, 2018 (GLOBE NEWSWIRE) -- The worldwide anaesthesia drugs market is predicted to experience a compound annual growth rate of 3.5 percent between 2018 and 2023, driven by the development of new drugs, an increasing number of surgeries and falling costs. It is, of course, a hugely important industry too, allowing individuals to undergo vital medical procedures without experiencing pain or distress.
In light of the market’s continued growth prospects, European CEO spoke with Switzerland-based Sintetica. With almost 100 years of history behind it, Sintetica is one of the leading players in the anaesthetic and analgesic market. The pharmaceutical firm currently employs 300 people across five countries to develop new therapies in pain management.
Collaborating with strategic partners is essential to the work undertaken at Sintetica, as is adopting the right management style – one based on meritocracy and responsibility. Company CEO Augusto Mitidieri has achieved this through the creation of a “human-centred organisation,” where strict definitions and rigid hierarchies are replaced by dynamism and employee autonomy.
The company’s culture has allowed creativity and risk-taking to flourish, which recently resulted in the approval of a new spinal anaesthesia drug. Obtaining marketing authorisation in the US for Clorotekal, or spinal chloroprocaine, represents a huge achievement for the firm, which has become one of just a handful of small to medium-sized companies to register an original pharmaceutical product in the US.
With its international network growing all the time, Sintetica has now registered products in more than 100 different markets. By continuing to value openness over inflexibility, the company is sure to create many more exciting medical products in the years to come.
For more about Sintetica and how its anaesthetics and analgesics are helping to reduce pressure on health services, check out the latest edition of European CEO, available in print, on tablet and online now:
World News Media is a leading publisher of quality financial and business magazines, which enjoys a global distribution network that includes subscriber lists of prominent decision-makers around the world.
CONTACT INFORMATION
World News Media
Elizabeth Matsangou
Editorial Department
+44 (0)20 7553 4162
elizabeth.matsangou@wnmedia.com